SCHEMBL4633855

SCHEMBL4633855

O=CNC(=O)c1ccccc1NC(=O)c1snc(Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.41
ALDH1A1 P00352 5/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPT P10636 4/20 0.40
HTT P42858 2/20 0.40
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
TP53 P04637 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30430210 0.83 KDM4E (0.50) ALDH1A1KMT2AMEN1HPGDNPSR1
SCHEMBL4632412 0.83 KDM4E (0.50) ALDH1A1KMT2AMEN1HPGDNPSR1
SCHEMBL14302077 0.78 HDAC1 (0.52) ALDH1A1CYP1A2CYP2C19KMT2AMEN1
SCHEMBL17342166 0.78 HTT (0.54) ALDH1A1CYP1A2KMT2AHTTUSP2
SCHEMBL28540549 0.78 SMN1; SMN2 (0.54) F10ALDH1A1CYP1A2CYP2C19KMT2A
SCHEMBL16080074 0.77 USP2 (0.40) ALDH1A1CYP1A2CYP2C19KMT2AMEN1
SCHEMBL22380 0.74 ALDH1A1 (0.48) ALDH1A1CYP1A2KMT2AMEN1MAPT
SCHEMBL10213140 0.74 KMT2A (0.40) ALDH1A1CYP1A2CYP2C19KMT2AMEN1
SCHEMBL28551538 0.74 USP2 (0.40) ALDH1A1CYP1A2CYP2C19KMT2AMEN1
SCHEMBL29395460 0.74 ALDH1A1 (0.48) ALDH1A1CYP1A2KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110719908-B Process for preparing 3, 4-dichloro-N- (2-cyanophenyl) -5-isothiazolecarboxamide 拜耳股份公司 2023-05-26 CN disclosed
US-11220487-B2 Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide BAYER AKTIENGESELLSCHAFT (DE) 2022-01-11 US disclosed
US-11220487-B2 Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide BAYER AKTIENGESELLSCHAFT (DE) 2022-01-11 US disclosed
EP-3638653-B1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLECARBOXAMIDE BAYER AG (DE) 2021-12-15 EP disclosed
EP-3638653-B1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLECARBOXAMIDE BAYER AG (DE) 2021-12-15 EP disclosed
US-20200140401-A1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLECARBOXAMIDE BAYER AKTIENGESELLSCHAFT (DE) 2020-05-07 US disclosed
US-20200140401-A1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLECARBOXAMIDE BAYER AKTIENGESELLSCHAFT (DE) 2020-05-07 US disclosed
EP-3638653-A1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLECARBOXAMIDE Bayer Aktiengesellschaft (DE) 2020-04-22 EP disclosed
CN-110719908-A Process for the preparation of 3, 4-dichloro-N- (2-cyanophenyl) -5-isothiazolecarboxamide 拜耳股份公司 2020-01-21 CN disclosed
WO-2018228984-A1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLECARBOXAMIDE BAYER AKTIENGESELLSCHAFT (DE) 2018-12-20 WO disclosed
EP-2573077-B1 METHOD FOR PRODUCING 3,4-DICHLOR-N-(2-CYANO-PHENYL)-5-ISOTHIAZOLE CARBOXAMIDE BAYER CROPSCIENCE AG (DE) 2017-10-04 EP disclosed
EP-2573077-B1 METHOD FOR PRODUCING 3,4-DICHLOR-N-(2-CYANO-PHENYL)-5-ISOTHIAZOLE CARBOXAMIDE BAYER CROPSCIENCE AG (DE) 2017-10-04 EP disclosed
EP-2573077-A1 Method for producing 3,4-dichlor-N-(2-cyano-phenyl)-5-isothiazole carboxamide Bayer CropScience AG (DE) 2013-03-27 EP disclosed
EP-2573077-A1 Method for producing 3,4-dichlor-N-(2-cyano-phenyl)-5-isothiazole carboxamide Bayer CropScience AG (DE) 2013-03-27 EP disclosed
EP-1926717-B1 Process for preparing 3,4-dichloro-N-(2-cyanophenyl)-5-isothiazole-carboxamide BAYER CROPSCIENCE AG (DE) 2013-02-27 EP disclosed
EP-1926717-B1 Process for preparing 3,4-dichloro-N-(2-cyanophenyl)-5-isothiazole-carboxamide BAYER CROPSCIENCE AG (DE) 2013-02-27 EP disclosed
EP-1926717-A1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLE­CARBOXAMIDE Bayer CropScience Aktiengesellschaft (DE) 2008-06-04 EP disclosed
WO-2007031146-A1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLE­CARBOXAMIDE BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-03-22 WO disclosed
WO-2007031146-A1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLE­CARBOXAMIDE BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11220487-B2 Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide SPECC1L, CCNL2, MCM4 F10 1983/4885ALDH1A1 2161/4885CYP1A2 2162/4885
US-20200140401-A1 PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLECARBOXAMIDE SPECC1L, CCNL2, MCM4 F10 1983/4885ALDH1A1 2161/4885CYP1A2 2162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.